Cardialysis B.V. deploys Heartlab's CardioNow

Heartlab will implement its CardioNow telecardiology and image management system for cardiovascular drug and device studies at Cardialysis B.V., a cardiology contract research organization in Rotterdam, The Netherlands.
           
With the technology, Cardialysis B.V. clients can use the web-based system to handle receipt, tracking, archiving, and analysis of complex cardiac images from hospital investigator sites around the world.
           
Heartlab's web-based CardioNow technology enables electronic sharing of patient angiograms and ultrasound studies required by cardiovascular device and drug clinical trials. Within minutes of patient enrollment, complete DICOM studies can be transferred from investigator sites to angiographic and ultrasound core worldwide labs, Heartlab said.
           
Additionally, these studies can be made available online for simultaneous review by other parties, such as clinical event committee members, safety monitoring board members and trial sponsors.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.